Skip to main content
Midas Edge

Antiaging Quantum Living Inc.

For the period ended Mar 31, 2026. Filed Jul 14, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Jul 14, 2026

AAQLStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

In accordance with the Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 14th day of July, 2026.

Antiaging Quantum Living Inc.
By:/s/ Barry Wan
Barry Wan, President
Chief Executive Officer

In accordance with the requirements of the Securities and Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities indicated and on the dates stated.

Dated: July 14, 2026By:/s/ Barry Wan
Barry Wan
CEO, CFO, Sec. and Director

EXHIBIT INDEX

3.1*Certificate of Amendment of the Certificate of Incorporation (filed as exhibit to the Form 8-K filed with the SEC on June 21, 2024)
3.2*By-laws (filed as an Exhibit to Form S-1 filed with the SEC on May 2, 2016)
10.1***Assignment and Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Barry Wan, as assignor, and Empire Street Capital Inc., as assignee, incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.2***Assignment and Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., New Lite Ventures LLC, as assignor, and Atlantic Equity Holdings Inc., as assignee, incorporated by reference to Exhibit 10.2 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.3***Assignment and Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Hemeihui E-Commerce Co., Ltd., as assignor, Antiaging Doctor Hangzhou Holding Ltd., as original maker, and Atlantic Equity Holdings Inc., as assignee, incorporated by reference to Exhibit 10.3 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.4***Assignment and Amendment of Promissory Note, dated November 25, 2025, by and among Antiaging Quantum Living Inc., Hemeihui E-Commerce Co., Ltd., as assignor, Dao Ling Doctor (Zhejiang) Health Management Limited, as original maker, and Empire Street Capital Inc., as assignee, incorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.5***Unanimous Written Consent of the Stockholder, dated November 25, 2025, incorporated by reference to Exhibit 10.5 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.6***Promissory Note, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Barry Wan, in the principal amount of $428,789.50, incorporated by reference to Exhibit 10.6 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.7***Promissory Note, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and New Lite Ventures LLC, in the principal amount of $29,571.00, incorporated by reference to Exhibit 10.7 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.8***Promissory Note, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Hemeihui E-Commerce Co., Ltd., in the principal amount of $538,568.00, relating to Antiaging Doctor Hangzhou Holding Ltd., incorporated by reference to Exhibit 10.8 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.9***Promissory Note, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Hemeihui E-Commerce Co., Ltd., in the principal amount of $287,174.00, relating to Dao Ling Doctor (Zhejiang) Health Management Limited, incorporated by reference to Exhibit 10.9 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
10.10***Promissory Note, dated December 31, 2024, by and between Antiaging Quantum Living Inc. and Tairan Baohe Insurance Sales Co., Ltd., in the principal amount of $383,598.00, incorporated by reference to Exhibit 10.10 to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
31.1**Certification of Principal Executive Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934, as Amended.
31.2**Certification of Principal Financial Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934, as Amended.
32.1**Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**Inline XBRL Instance Document
101.SCH**Inline XBRL Taxonomy Extension Schema Document
101.CAL**Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF**Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB**Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE**Inline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
*Incorporated by reference to the Company’s Form 8-K as filed with the SEC on June 21, 2024.
**Filed herewith *** Incorporated by reference to the Company’s Registration Statement on Form S-1 filed with the SEC on December 12, 2025.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.